In today’s Zacks Research Daily, analysts present reports on 16 major stocks, including Microsoft Corp. (MSFT), Amazon.com, Inc. (AMZN), and Eli Lilly and Co. (LLY). Microsoft’s fiscal first-quarter 20256 results show strong performance driven by cloud and AI business momentum. Amazon reported robust third-quarter earnings and revenue growth, led by AWS. Eli Lilly’s Q3 earnings exceeded estimates, driven by strong demand for key drugs.

Microsoft’s shares have outperformed the Zacks Computer – Software industry this year. Azure’s 40% growth and diversified revenue streams contribute to its stability. Amazon’s strong third-quarter results were driven by advertising revenue growth and robust Prime engagement. Eli Lilly’s popular GLP-1 drugs remain key drivers of its sales growth.

While Microsoft expects a 15.1% growth in net sales for fiscal 2026, capacity constraints may limit revenue capture. Amazon’s profitability was impacted by flat operating income and high infrastructure investments. Eli Lilly faces headwinds from declining sales of some drugs and potential competition in the market.

In Featured Research Reports, analysts discuss companies like The Charles Schwab Corp. (SCHW), Canadian Natural Resources Ltd. (CNQ), and Yum! Brands, Inc. (YUM). Schwab’s strategic acquisitions enhance profits but could lead to higher costs. Yum! Brands benefits from digital efforts, but high costs and macro issues persist. Canadian Natural’s ownership in Athabasca Oil Sands project is expected to boost cash flow.

Read more at Nasdaq: Top Research Reports for Microsoft, Amazon.com & Eli Lilly